HCP, Inc. (NYSE:HCP) Receives Average Recommendation of “Buy” from Brokerages

Share on StockTwits

Shares of HCP, Inc. (NYSE:HCP) have earned a consensus rating of “Buy” from the sixteen brokerages that are currently covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $31.22.

HCP has been the subject of a number of analyst reports. Raymond James initiated coverage on shares of Adverum Biotechnologies in a research report on Thursday, June 13th. They issued a “market perform” rating for the company. TheStreet upgraded shares of Rent-A-Center from a “c” rating to a “b-” rating in a research report on Tuesday, May 7th. Morgan Stanley set a $111.00 price objective on shares of Procter & Gamble and gave the company a “buy” rating in a research report on Thursday, March 28th. Finally, KeyCorp downgraded shares of GTT Communications from an “overweight” rating to a “sector weight” rating in a research report on Monday, July 1st.

Shares of NYSE HCP traded down $0.90 during midday trading on Friday, reaching $31.74. The company’s stock had a trading volume of 1,859,787 shares, compared to its average volume of 2,588,113. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.90. HCP has a fifty-two week low of $24.47 and a fifty-two week high of $33.58. The stock’s 50 day moving average price is $32.21. The firm has a market cap of $15.17 billion, a P/E ratio of 17.44, a P/E/G ratio of 7.09 and a beta of 0.31.

HCP (NYSE:HCP) last released its quarterly earnings results on Wednesday, May 1st. The real estate investment trust reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.01. HCP had a net margin of 59.96% and a return on equity of 18.05%. The company had revenue of $436.15 million during the quarter, compared to the consensus estimate of $442.20 million. During the same period in the previous year, the business earned $0.48 earnings per share. The firm’s quarterly revenue was down 9.0% on a year-over-year basis. Sell-side analysts anticipate that HCP will post 1.74 earnings per share for the current year.

In other HCP news, Director Christine Garvey sold 3,405 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $29.80, for a total transaction of $101,469.00. Following the completion of the transaction, the director now directly owns 5,348 shares in the company, valued at $159,370.40. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.13% of the stock is owned by insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Comerica Securities Inc. acquired a new stake in HCP in the fourth quarter valued at $345,000. Raymond James Financial Services Advisors Inc. grew its holdings in HCP by 13.0% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 39,004 shares of the real estate investment trust’s stock valued at $1,089,000 after purchasing an additional 4,492 shares during the last quarter. Bessemer Group Inc. boosted its stake in shares of HCP by 32.9% during the fourth quarter. Bessemer Group Inc. now owns 1,332 shares of the real estate investment trust’s stock valued at $37,000 after acquiring an additional 330 shares during the last quarter. United Services Automobile Association boosted its stake in shares of HCP by 30.7% during the fourth quarter. United Services Automobile Association now owns 192,035 shares of the real estate investment trust’s stock valued at $5,364,000 after acquiring an additional 45,064 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of HCP by 11.8% during the fourth quarter. Geode Capital Management LLC now owns 7,752,843 shares of the real estate investment trust’s stock valued at $216,236,000 after acquiring an additional 821,285 shares during the last quarter. Institutional investors and hedge funds own 95.50% of the company’s stock.

HCP Company Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Featured Article: Options Trading

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.